US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist

9.320
-0.080-0.85%

Close Nov 29 13:00 ET

9.350
+0.030+0.32%

Post 17:02 ET

2.84BMarket Cap-6297P/E (TTM)

Iovance Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

29.86%-58.97M

-4.77%-98.43M

-22.51%-122.28M

-23.59%-361.82M

-8.11%-83.97M

-32.10%-84.08M

-21.02%-93.95M

-35.25%-99.82M

-28.44%-292.76M

-44.24%-77.67M

Net income from continuing operations

26.56%-83.54M

8.85%-97.1M

-5.22%-112.98M

-12.16%-444.04M

-10.50%-116.38M

-14.20%-113.76M

-7.23%-106.53M

-17.21%-107.37M

-15.67%-395.89M

-6.03%-105.32M

Operating gains losses

-126.05%-93K

--10K

---96K

--70K

---106K

--357K

----

Depreciation and amortization

12.89%11.15M

38.55%10.86M

73.90%9.91M

56.74%33.13M

70.21%9.71M

89.83%9.88M

49.41%7.84M

14.44%5.7M

51.18%21.14M

27.84%5.71M

Deferred tax

-22.37%-1.52M

-205.66%-1.46M

---1.41M

---3.48M

---1.76M

---1.24M

---477K

--0

Change In working capital

-326.10%-13.32M

-237.50%-38.71M

-153.71%-32.55M

-125.48%-6.52M

295.87%11.89M

-45.73%5.89M

-77.66%-11.47M

-24.64%-12.83M

-111.78%-2.89M

-85.75%3M

-Change in receivables

-73,324.24%-24.16M

-94,960.61%-31.37M

---83K

---149K

--33K

---33K

--0

----

-Change in inventory

-3,171.47%-10.87M

7.23%-8.86M

---6.74M

---10.12M

---923K

--354K

---9.55M

--0

-Change in prepaid assets

-214.92%-2.47M

92.55%-211K

239.16%5.89M

-372.39%-10.06M

-280.89%-5.15M

192.92%2.15M

-368.88%-2.83M

-13.89%-4.23M

-176.76%-2.13M

26.04%2.85M

-Change in payables and accrued expense

340.18%27.14M

21.44%4.42M

-378.19%-28.83M

1,984.92%24.6M

744.95%20.83M

-55.02%6.17M

147.11%3.64M

17.05%-6.03M

-95.73%1.18M

-87.24%2.47M

-Change in other current liabilities

-4.69%-2.95M

0.11%-2.69M

-8.56%-2.79M

-455.82%-10.79M

-17.85%-2.72M

-424.81%-2.81M

-1,369.81%-2.69M

-472.32%-2.57M

66.98%-1.94M

-368.15%-2.31M

Cash from discontinued investing activities

Operating cash flow

29.86%-58.97M

-4.77%-98.43M

-22.51%-122.28M

-23.59%-361.82M

-8.11%-83.97M

-32.10%-84.08M

-21.02%-93.95M

-35.25%-99.82M

-28.44%-292.76M

-44.24%-77.67M

Investing cash flow

Cash flow from continuing investing activities

38.24%-48.8M

125.65%40.22M

-172.69%-111.51M

-160.53%-155.24M

-15,901.52%-72.85M

-207.19%-79.01M

-263.72%-156.78M

77.30%153.4M

194,184.09%256.46M

-99.34%461K

Net PPE purchase and sale

36.04%-2.29M

95.36%-442K

26.36%-4.17M

-9.13%-22.29M

-16.78%-3.53M

-157.89%-3.58M

-108.04%-9.52M

50.49%-5.66M

45.64%-20.43M

60.07%-3.02M

Net business purchase and sale

--0

---52.57M

---212.63M

--253K

---3.38M

---209.51M

--0

Net investment purchase and sale

35.45%-46.51M

-34.68%40.66M

-134.43%-54.76M

-71.22%79.68M

-2,097.39%-69.57M

-195.95%-72.06M

-37.96%62.25M

62.38%159.06M

634.31%276.88M

-95.47%3.48M

Cash from discontinued investing activities

Investing cash flow

38.24%-48.8M

125.65%40.22M

-172.69%-111.51M

-160.53%-155.24M

-15,901.52%-72.85M

-207.19%-79.01M

-263.72%-156.78M

77.30%153.4M

194,184.09%256.46M

-99.34%461K

Financing cash flow

Cash flow from continuing financing activities

-79.31%41.95M

14,809.76%152.83M

-25.02%193.58M

143.47%462.96M

-99.50%962K

90,033.33%202.8M

149.59%1.03M

18,119.62%258.17M

-20.53%190.15M

4,492.17%190.58M

Net issuance payments of debt

----

--0

----

--0

----

Net common stock issuance

-76.61%47.52M

--151.87M

-23.91%197.91M

144.47%463.28M

-100.00%1K

--203.18M

--0

--260.1M

-6.72%189.5M

--189.5M

Proceeds from stock option exercised by employees

--713K

47.21%1.95M

--364K

-24.99%2.47M

6.90%1.15M

--0

127.84%1.33M

--0

-90.61%3.3M

-74.14%1.07M

Net other financing activities

-1,556.20%-6.28M

-232.23%-1M

-143.70%-4.7M

-5.51%-2.8M

---186K

---379K

---301K

---1.93M

---2.65M

--0

Cash from discontinued financing activities

Financing cash flow

-79.31%41.95M

14,809.76%152.83M

-25.02%193.58M

143.47%462.96M

-99.50%962K

90,033.33%202.8M

149.59%1.03M

18,119.62%258.17M

-20.53%190.15M

4,492.17%190.58M

Net cash flow

Beginning cash position

-20.69%235.11M

-74.43%140.62M

-23.87%181.32M

182.47%238.16M

167.76%334.15M

158.89%296.44M

458.61%549.91M

182.47%238.16M

15.73%84.31M

92.96%124.8M

Current changes in cash

-265.78%-65.82M

137.89%94.62M

-112.90%-40.21M

-135.17%-54.1M

-237.48%-155.85M

285.80%39.7M

-1,654.74%-249.71M

2,106.16%311.75M

1,242.60%153.85M

477.24%113.37M

Effect of exchange rate changes

162.87%1.25M

96.68%-125K

---491K

---2.74M

--3.02M

---1.99M

---3.77M

--0

----

End cash Position

-48.96%170.54M

-20.69%235.11M

-74.43%140.62M

-23.87%181.32M

167.76%334.15M

158.89%296.44M

458.61%549.91M

182.47%238.16M

Free cash flow

30.12%-61.26M

4.45%-98.87M

-19.88%-126.45M

-22.65%-384.11M

-8.43%-87.5M

-34.79%-87.66M

-25.86%-103.47M

-23.74%-105.48M

-17.95%-313.18M

-31.39%-80.69M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	29.86%-58.97M	-4.77%-98.43M	-22.51%-122.28M	-23.59%-361.82M	-8.11%-83.97M	-32.10%-84.08M	-21.02%-93.95M	-35.25%-99.82M	-28.44%-292.76M	-44.24%-77.67M
Net income from continuing operations	26.56%-83.54M	8.85%-97.1M	-5.22%-112.98M	-12.16%-444.04M	-10.50%-116.38M	-14.20%-113.76M	-7.23%-106.53M	-17.21%-107.37M	-15.67%-395.89M	-6.03%-105.32M
Operating gains losses	-126.05%-93K	--10K	---96K	--70K	---106K	--357K	----	----	----	----
Depreciation and amortization	12.89%11.15M	38.55%10.86M	73.90%9.91M	56.74%33.13M	70.21%9.71M	89.83%9.88M	49.41%7.84M	14.44%5.7M	51.18%21.14M	27.84%5.71M
Deferred tax	-22.37%-1.52M	-205.66%-1.46M	---1.41M	---3.48M	---1.76M	---1.24M	---477K	--0	--0	--0
Change In working capital	-326.10%-13.32M	-237.50%-38.71M	-153.71%-32.55M	-125.48%-6.52M	295.87%11.89M	-45.73%5.89M	-77.66%-11.47M	-24.64%-12.83M	-111.78%-2.89M	-85.75%3M
-Change in receivables	-73,324.24%-24.16M	-94,960.61%-31.37M	---83K	---149K	---149K	--33K	---33K	--0	--0	----
-Change in inventory	-3,171.47%-10.87M	7.23%-8.86M	---6.74M	---10.12M	---923K	--354K	---9.55M	--0	--0	--0
-Change in prepaid assets	-214.92%-2.47M	92.55%-211K	239.16%5.89M	-372.39%-10.06M	-280.89%-5.15M	192.92%2.15M	-368.88%-2.83M	-13.89%-4.23M	-176.76%-2.13M	26.04%2.85M
-Change in payables and accrued expense	340.18%27.14M	21.44%4.42M	-378.19%-28.83M	1,984.92%24.6M	744.95%20.83M	-55.02%6.17M	147.11%3.64M	17.05%-6.03M	-95.73%1.18M	-87.24%2.47M
-Change in other current liabilities	-4.69%-2.95M	0.11%-2.69M	-8.56%-2.79M	-455.82%-10.79M	-17.85%-2.72M	-424.81%-2.81M	-1,369.81%-2.69M	-472.32%-2.57M	66.98%-1.94M	-368.15%-2.31M
Cash from discontinued investing activities
Operating cash flow	29.86%-58.97M	-4.77%-98.43M	-22.51%-122.28M	-23.59%-361.82M	-8.11%-83.97M	-32.10%-84.08M	-21.02%-93.95M	-35.25%-99.82M	-28.44%-292.76M	-44.24%-77.67M
Investing cash flow
Cash flow from continuing investing activities	38.24%-48.8M	125.65%40.22M	-172.69%-111.51M	-160.53%-155.24M	-15,901.52%-72.85M	-207.19%-79.01M	-263.72%-156.78M	77.30%153.4M	194,184.09%256.46M	-99.34%461K
Net PPE purchase and sale	36.04%-2.29M	95.36%-442K	26.36%-4.17M	-9.13%-22.29M	-16.78%-3.53M	-157.89%-3.58M	-108.04%-9.52M	50.49%-5.66M	45.64%-20.43M	60.07%-3.02M
Net business purchase and sale	--0	--0	---52.57M	---212.63M	--253K	---3.38M	---209.51M	--0	--0	--0
Net investment purchase and sale	35.45%-46.51M	-34.68%40.66M	-134.43%-54.76M	-71.22%79.68M	-2,097.39%-69.57M	-195.95%-72.06M	-37.96%62.25M	62.38%159.06M	634.31%276.88M	-95.47%3.48M
Cash from discontinued investing activities
Investing cash flow	38.24%-48.8M	125.65%40.22M	-172.69%-111.51M	-160.53%-155.24M	-15,901.52%-72.85M	-207.19%-79.01M	-263.72%-156.78M	77.30%153.4M	194,184.09%256.46M	-99.34%461K
Financing cash flow
Cash flow from continuing financing activities	-79.31%41.95M	14,809.76%152.83M	-25.02%193.58M	143.47%462.96M	-99.50%962K	90,033.33%202.8M	149.59%1.03M	18,119.62%258.17M	-20.53%190.15M	4,492.17%190.58M
Net issuance payments of debt	----	----	----	--0	----	----	----	----	--0	----
Net common stock issuance	-76.61%47.52M	--151.87M	-23.91%197.91M	144.47%463.28M	-100.00%1K	--203.18M	--0	--260.1M	-6.72%189.5M	--189.5M
Proceeds from stock option exercised by employees	--713K	47.21%1.95M	--364K	-24.99%2.47M	6.90%1.15M	--0	127.84%1.33M	--0	-90.61%3.3M	-74.14%1.07M
Net other financing activities	-1,556.20%-6.28M	-232.23%-1M	-143.70%-4.7M	-5.51%-2.8M	---186K	---379K	---301K	---1.93M	---2.65M	--0
Cash from discontinued financing activities
Financing cash flow	-79.31%41.95M	14,809.76%152.83M	-25.02%193.58M	143.47%462.96M	-99.50%962K	90,033.33%202.8M	149.59%1.03M	18,119.62%258.17M	-20.53%190.15M	4,492.17%190.58M
Net cash flow
Beginning cash position	-20.69%235.11M	-74.43%140.62M	-23.87%181.32M	182.47%238.16M	167.76%334.15M	158.89%296.44M	458.61%549.91M	182.47%238.16M	15.73%84.31M	92.96%124.8M
Current changes in cash	-265.78%-65.82M	137.89%94.62M	-112.90%-40.21M	-135.17%-54.1M	-237.48%-155.85M	285.80%39.7M	-1,654.74%-249.71M	2,106.16%311.75M	1,242.60%153.85M	477.24%113.37M
Effect of exchange rate changes	162.87%1.25M	96.68%-125K	---491K	---2.74M	--3.02M	---1.99M	---3.77M	--0	----	----
End cash Position	-48.96%170.54M	-20.69%235.11M	-74.43%140.62M	-23.87%181.32M	-23.87%181.32M	167.76%334.15M	158.89%296.44M	458.61%549.91M	182.47%238.16M	182.47%238.16M
Free cash flow	30.12%-61.26M	4.45%-98.87M	-19.88%-126.45M	-22.65%-384.11M	-8.43%-87.5M	-34.79%-87.66M	-25.86%-103.47M	-23.74%-105.48M	-17.95%-313.18M	-31.39%-80.69M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data